Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03192072 · ClinicalTrials.gov registry record
A Rapid Test for Acute Respiratory Illness
A clinical trial, sponsored by Duke University.
- Completed
- Registry status
- 783
- Enrollment target
NCT03192072: Completed study, sponsored by Duke University.
NCT03192072 is a clinical trial that has completed, run by Duke University. The registered enrollment target is 783 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03192072 has completed, sponsored by Duke University.
- COMPLETED
- Registry status
- 783 participants
- Enrollment target
Study Summary
The primary purpose of this study is to support the development of a host response test for acute respiratory illness to identify bacterial, viral or NB/NV etiologies as compared to a clinical adjudication reference standard. Secondary objectives include: 1. Evaluate the effect of age on the performance of the HR-ARI test 2. Evaluate the effect of race/ethnicity on the performance of the HR-ARI test 3. Evaluate the effect of geography on the performance of the HR-ARI test
Primary Outcome
Number of assay positives that agree with the reference standard / \[Number of assay positives that agree with the reference standard + Number of assay positives that disagree with the reference standard\]
Interventions
- DIAGNOSTIC_TEST Host Gene Expression
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 783 participants |
| Start Date | 2017-07-17 |
| Est. Completion | 2019-12-19 |
What the finished NCT03192072 record still lists
NCT03192072 is an observational study that tracks outcomes without assigning an intervention. The registered 783 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which Host Gene Expression is the first listed.
NCT03192072 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03192072 about?
NCT03192072 is a clinical study titled "A Rapid Test for Acute Respiratory Illness". The primary purpose of this study is to support the development of a host response test for acute respiratory illness to identify bacterial, viral or NB/NV etiologies as compared to a clinical adjudication reference standard. Secondary objectives include: 1. Evaluate the effect of age on the perfo...
What is the current status of trial NCT03192072?
This trial is currently completed. The enrollment target is 783 participants. The study started on 2017-07-17. Estimated completion is 2019-12-19.
What interventions are being tested in trial NCT03192072?
The interventions under investigation include: Host Gene Expression (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT03192072?
This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06575192 · 783 participants · Phase 3
Evaluation of the Safety and Effectiveness of ARTIA Reconstructive Tissue Matrix Breast Reconstruction (ADORA) in Adult Participants
- NCT06118723 · 784 participants
The SUPRAMAX Study: Supramaximal Resection Versus Maximal Resection for High-Grade Glioma Patients (ENCRAM 2201)
- NCT06498128 · 785 participants
Registry to Collect Information on Pregnancy, Neonatal, and Infant Outcomes in Pregnant Women Exposed to QUVIVIQ®
- NCT07276724 · 786 participants · Phase 3
A Study to Investigate GB-0895 Adjunctive Therapy in Adults and Adolescents With Severe Uncontrolled Asthma (SOLAIRIA-1)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI